Omeprax-Drossapharm 40mg, magensaftresistente Kapseln

7680659790120 CH-65979 Magensaftresistente Kapseln

Associated product:

OMEPRAX Drossapharm caps 40 mg bte 28 pce
Omeprax-Drossapharm 40mg, magensaftresistente Kapseln
Omeprax-Drossapharm 40mg, magensaftresistente Kapseln
Omeprax-Drossapharm 40mg, magensaftresistente Kapseln
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Kapsel(n)
Galenic form
Magensaftresistente Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/08/2024
Patient information leaflet
Français
12/08/2024
Patient information leaflet
Italien
12/08/2024
Summary of Product Characteristics
Allemand
12/08/2024
Summary of Product Characteristics
Français
12/08/2024
Summary of Product Characteristics
Italien
12/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
160.05 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
3.03 MG Substance HBESI

Reimbursement information

Public price
CHF 36.55
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2016

Authorization holder

Drossapharm AG

4051 Basel

Authorization information

Swissmedic authorization number
65979
Drug name
Omeprax-Drossapharm, magensaftresistente Kapseln
Galenic form
KAHAM
ATC Code
A02BC01
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
04/11/2015
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
Ulcustherapie, Zollinger-Ellison-Syndrom

Package details

Description (FR)
OMEPRAX Drossapharm caps 40 mg bte 28 pce
Description (DE)
OMEPRAX Drossapharm Kaps 40 mg Ds 28 Stk
Market launch
04/11/2015
Narcotic (BTM)
No

Original drug

Antramups, Tabletten
GTIN: 7680543800386
CHF 16.20
View original

Other package sizes (10)

OMEPRAX Drossapharm caps 10 mg bte 14 pce
14 KAP
GTIN: 7680659790014
View
OMEPRAX Drossapharm caps 10 mg bte 28 pce
28 KAP
GTIN: 7680659790021
View
OMEPRAX Drossapharm caps 10 mg bte 56 pce
56 KAP
GTIN: 7680659790038
View
OMEPRAX Drossapharm caps 10 mg bte 98 pce
98 KAP
GTIN: 7680659790045
View
OMEPRAX Drossapharm caps 20 mg bte 7 pce
7 KAP
GTIN: 7680659790052
View
OMEPRAX Drossapharm caps 20 mg bte 14 pce
14 KAP
GTIN: 7680659790069
View
OMEPRAX Drossapharm caps 20 mg bte 28 pce
28 KAP
GTIN: 7680659790076
View
OMEPRAX Drossapharm caps 20 mg bte 56 pce
56 KAP
GTIN: 7680659790083
View
OMEPRAX Drossapharm caps 20 mg bte 98 pce
98 KAP
GTIN: 7680659790090
View
OMEPRAX Drossapharm caps 40 mg bte 7 pce
7 KAP
GTIN: 7680659790106
View